Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04251273 · ClinicalTrials.gov registry record · NA
Text Message Quit Vaping Intervention for Young Adults
A NA study, sponsored by Truth Initiative.
- Completed
- Registry status
- NA
- Development phase
- 2,588
- Enrollment target
NCT04251273: Completed NA study, sponsored by Truth Initiative.
NCT04251273 is a NA study that has completed, run by Truth Initiative. The registered enrollment target is 2,588 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04251273, a NA study, has completed, sponsored by Truth Initiative.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,588 participants
- Enrollment target
Study Summary
This research study, conducted by Truth Initiative, will help us learn how text messaging can help young adults between 18 and 24 years of age quit vaping.
Primary Outcome
Number of participant who responded "No" to the question "In the past 30 days, did you vape at all, even a puff of someone else's?" Denominator is all randomized participants.
Interventions
- OTHER This is Quitting
- OTHER Assessment only Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,588 participants |
| Start Date | 2019-12-19 |
| Est. Completion | 2020-11-12 |
| Phase | NA |
What the finished NCT04251273 record still lists
NCT04251273 is an interventional study that assigns participants to a tested intervention. Its 2,588 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% higher).
The record links to 0 conditions, and to 2 interventions - of which This is Quitting is the first listed.
NCT04251273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04251273 about?
NCT04251273 is a clinical study titled "Text Message Quit Vaping Intervention for Young Adults". This research study, conducted by Truth Initiative, will help us learn how text messaging can help young adults between 18 and 24 years of age quit vaping.
What is the current status of trial NCT04251273?
This trial is currently completed. It is a NA study. The enrollment target is 2,588 participants. The study started on 2019-12-19. Estimated completion is 2020-11-12.
What interventions are being tested in trial NCT04251273?
The interventions under investigation include: This is Quitting (OTHER), Assessment only Control (OTHER).
Who is sponsoring clinical trial NCT04251273?
This trial is sponsored by Truth Initiative, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04251273's enrollment target sits among peer trials
2,588 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI